![hero section background image](/themes/custom/fishawack/media/content/images/background/header-referral.jpg)
CellCompass is the Novartis platform to help you navigate CAR-T therapy for your patients
Information and resources helping you assess your patient’s eligibility for CAR-T therapy, including a mechanism of action video and guide for healthcare professionals.
CellCompass is the Novartis platform to help you navigate CAR-T therapy for your patients
Information and resources helping you assess your patient’s eligibility for CAR-T therapy, including a mechanism of action video and guide for healthcare professionals.
Resources
![](https://cellcompass-staging.s3.amazonaws.com/content/default/2023-03/shutterstock-1463202677%402x.png)
My T-Cell Therapies site
See how CAR-T immunotherapy is used for treating Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL).